2023 Form 5500 filing — Glenmark Pharmaceuticals, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241009160124NAL0009383747001) for Glenmark Pharmaceuticals, Inc. 401(K) Plan, reported by Glenmark Pharmaceuticals, Inc. under EIN 75-3102019 and plan number 001. It reports 663 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241009160124NAL0009383747001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Glenmark Pharmaceuticals, Inc.
- EIN
- 75-3102019
- Plan number
- 001
- Location
- Mahwah, NJ
- Participants
- 663
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $21,387,844
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $21,387,844
- Employer contributions
- $996,047
- Participant contributions
- $2,071,974
- Total income / additions
- $6,845,997
- Benefits paid
- $2,718,108
- Administrative expenses
- $119,520
- Total expenses
- $2,840,690
- Net increase / (decrease)
- $4,005,307
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Empower Annuity Insurance Company | RECORDKEEPER | $48,599 | $0 |
| The Angell Pension Group Inc | CONTRACT ADMIN | $35,380 | not reported in the loaded dataset |
| Lpl Financial | INVESTMENT ADVISOR | $18,743 | not reported in the loaded dataset |
| Empower Advisory Group | INVESTMENT MANAGEMENT | $18,343 | not reported in the loaded dataset |